This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures such as monitoring of acetaminophen ...
The Dexcom G6 continuous monitoring system (Dexcom Inc) measures interstitial fluid glucose levels. The G6 system consists of 3 key parts: the sensor wire, a transmitter, and a display device. The ...
Dexcom has obtained European approval for the latest generation of its wearable diabetes sensor, the G7 continuous glucose monitor, for adults and children ages two and up. Designed to be 60% smaller ...
Global CGM device maker Dexcom has launched its latest CGM system in Singapore. Distributed through its partner DKSH Singapore, the prick-less Dexcom G6 CGM uses a wearable sensor and transmitter to ...
An interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.
The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
SINGAPORE--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback